Artículos (53) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. A novel bioadhesive semisolid formulation containing chitosan and tetracycline/layered clay complexes for local delivery into periodontal pockets

    Materials Technology, Vol. 29, Núm. B2, pp. B108-B113

  2. Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis

    Molecular Nutrition and Food Research, Vol. 58, Núm. 12, pp. 2379-2382

  3. An improved cryopreservation method for porcine buccal mucosa in ex vivo drug permeation studies using Franz diffusion cells

    European Journal of Pharmaceutical Sciences, Vol. 60, pp. 49-54

  4. Characterisation of Tunisian layered clay materials to be used in semisolid health care products

    Materials Technology, Vol. 29, Núm. B2, pp. B88-B95

  5. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus

    Hypertension, Vol. 64, Núm. 2, pp. 330-337

  6. Clays in complementary and alternative medicine

    Materials Technology, Vol. 29, Núm. B2, pp. B78-B81

  7. Design and physicochemical stability studies of paediatric oral formulations of sildenafil

    International Journal of Pharmaceutics, Vol. 460, Núm. 1-2, pp. 234-239

  8. Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa

    Colloids and Surfaces B: Biointerfaces, Vol. 116, pp. 183-192

  9. Development of a liquid chromatographic method for the quantification of paromomycin. Application to in vitro release and ex vivo permeation studies

    Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, Vol. 133, pp. 657-662

  10. Development, physical-chemical stability, and release studies of four alcohol-free spironolactone suspensions for use in pediatrics

    Dissolution Technologies, Vol. 21, Núm. 1, pp. 19-30

  11. Drug assessment by a Pharmacy and Therapeutics committee: From drug selection criteria to use in clinical practice

    Therapeutics and Clinical Risk Management, Vol. 10, Núm. 1, pp. 527-535

  12. Efectos de un programa de Atención Farmacéutica para pacientes con esclerosis múltiple sobre la adherencia al tratamiento inmunomodulador

    Ars pharmaceutica, Vol. 55, Núm. 1, pp. 37-44

  13. Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: Study protocol for a randomized controlled trial

    Trials, Vol. 15, Núm. 1

  14. Engineering of δ9-tetrahydrocannabinol delivery systems based on surface modified-PLGA nanoplatforms

    Colloids and Surfaces B: Biointerfaces, Vol. 123, pp. 114-122

  15. Enhancing effect of glucose microspheres in the viability of human mesenchymal stem cell suspensions for clinical administration

    Pharmaceutical Research, Vol. 31, Núm. 12, pp. 3515-3528

  16. Folk pharmaceutical formulations in western Mediterranean: Identification and safety of clays used in pelotherapy

    Journal of Ethnopharmacology, Vol. 155, Núm. 1, pp. 810-814

  17. Identificación de los costes de la provisión sostenible del servicio de Seguimiento Farmacoterapéutico

    Pharmaceutical care España, Vol. 16, Núm. 5, pp. 180-192

  18. Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: A randomised controlled trial (IPHIWWE study)

    Health and Quality of Life Outcomes, Vol. 12, Núm. 1

  19. Implementing smart pump technology in a pediatric intensive care unit: A cost-effective approach

    International Journal of Medical Informatics, Vol. 83, Núm. 2, pp. 99-105

  20. Importancia de la polietilenimina en biomedicina y sus aplicaciones en terapia génica

    Ars pharmaceutica, Vol. 55, Núm. 1, pp. 50-58